KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

NovoCure (NVCR) Assets Average (2016 - 2025)

Historic Assets Average for NovoCure (NVCR) over the last 11 years, with Q3 2025 value amounting to $1.3 billion.

  • NovoCure's Assets Average rose 710.36% to $1.3 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.3 billion, marking a year-over-year increase of 710.36%. This contributed to the annual value of $1.2 billion for FY2024, which is 210.18% up from last year.
  • Per NovoCure's latest filing, its Assets Average stood at $1.3 billion for Q3 2025, which was up 710.36% from $1.2 billion recorded in Q2 2025.
  • Over the past 5 years, NovoCure's Assets Average peaked at $1.3 billion during Q3 2025, and registered a low of $1.1 billion during Q1 2021.
  • For the 5-year period, NovoCure's Assets Average averaged around $1.2 billion, with its median value being $1.2 billion (2023).
  • As far as peak fluctuations go, NovoCure's Assets Average surged by 13099.37% in 2021, and later tumbled by 416.02% in 2024.
  • NovoCure's Assets Average (Quarter) stood at $1.1 billion in 2021, then increased by 4.69% to $1.2 billion in 2022, then decreased by 3.1% to $1.1 billion in 2023, then grew by 7.43% to $1.2 billion in 2024, then increased by 5.86% to $1.3 billion in 2025.
  • Its Assets Average stands at $1.3 billion for Q3 2025, versus $1.2 billion for Q2 2025 and $1.2 billion for Q1 2025.